Literature DB >> 9267000

Identification of the gene coding for rhesus cytomegalovirus glycoprotein B and immunological analysis of the protein.

B Kropff1, M Mach.   

Abstract

The nucleotide sequence of the gene encoding glycoprotein B (gB) of rhesus cytomegalovirus (RhCMV) was determined and the protein characterized. The open reading frame of gB encoded a protein of 854 amino acids with 60% identity and 75% similarity at the amino acid level to human cytomegalovirus (HCMV) gB. Cysteine residues in the extraluminal part of the protein are perfectly conserved. Out of the 16 potential N-linked glycosylation sites present in HCMV gB, 15 are conserved in RhCMV gB. Immunoblot analyses with antisera detected three bands of 150 kDa, 90-110 kDa and 55 kDa representing the full-length gB as well as the proteolytic cleavage products. Cross-reactivity and cross-neutralization of a number of HCMV gB-specific monoclonal antibodies with RhCMV gB indicated sharing of immunogenic epitopes between the two molecules. The RhCMV gB regions corresponding to antigenic domains AD-1, 2 and 3 of HCMV gB were immunogenic during natural RhCMV infection with the AD-1 region being the immunodominant domain. The data indicate that RhCMV might represent a useful model to investigate pathogenesis and immune surveillance of cytomegaloviruses.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267000     DOI: 10.1099/0022-1317-78-8-1999

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  8 in total

Review 1.  Animal Models of Congenital Cytomegalovirus Transmission: Implications for Vaccine Development.

Authors:  Hunter K Roark; Jennifer A Jenks; Sallie R Permar; Mark R Schleiss
Journal:  J Infect Dis       Date:  2020-03-05       Impact factor: 5.226

2.  T cells engineered with a cytomegalovirus-specific chimeric immunoreceptor.

Authors:  Florian Full; Manfred Lehner; Veronika Thonn; Gabriel Goetz; Brigitte Scholz; Kerstin B Kaufmann; Michael Mach; Hinrich Abken; Wolfgang Holter; Armin Ensser
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

3.  Antigenic domain 1 is required for oligomerization of human cytomegalovirus glycoprotein B.

Authors:  William J Britt; Michael A Jarvis; Derek D Drummond; Michael Mach
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

4.  Pathogenesis of experimental rhesus cytomegalovirus infection.

Authors:  K M Lockridge; G Sequar; S S Zhou; Y Yue; C P Mandell; P A Barry
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  Specific inhibition of human cytomegalovirus glycoprotein B-mediated fusion by a novel thiourea small molecule.

Authors:  Thomas R Jones; Shi-Wu Lee; Stephen V Johann; Vladimir Razinkov; Robert J Visalli; Boris Feld; Jonathan D Bloom; John O'Connell
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 6.  Rhesus CMV: an emerging animal model for human CMV.

Authors:  Colin Powers; Klaus Früh
Journal:  Med Microbiol Immunol       Date:  2008-01-11       Impact factor: 3.402

Review 7.  Rhesus monkeys for a nonhuman primate model of cytomegalovirus infections.

Authors:  Hannah L Itell; Amitinder Kaur; Jesse D Deere; Peter A Barry; Sallie R Permar
Journal:  Curr Opin Virol       Date:  2017-09-06       Impact factor: 7.090

8.  A gB/CD3 bispecific BiTE antibody construct for targeting Human Cytomegalovirus-infected cells.

Authors:  Charlotte U Brey; Julia Proff; Natascha Teufert; Benjamin Salzer; Johannes Brozy; Markus Münz; Jochen Pendzialek; Armin Ensser; Wolfgang Holter; Manfred Lehner
Journal:  Sci Rep       Date:  2018-11-28       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.